Get the Stockscreener App
73.91
0.03%
-0.02
Pre-market:
73.80
-0.11
-0.15%
Hologic Inc stock is traded at $73.91, with a volume of 2.82M.
It is down -0.03% in the last 24 hours and up +9.51% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$73.93
Open:
$73.94
24h Volume:
2.82M
Relative Volume:
1.07
Market Cap:
$16.44B
Revenue:
$4.04B
Net Income/Loss:
$557.10M
P/E Ratio:
30.67
EPS:
2.4102
Net Cash Flow:
$916.70M
1W Performance:
-0.11%
1M Performance:
+9.51%
6M Performance:
+26.99%
1Y Performance:
-8.61%
1-Day Range:
$73.86
$74.00
1-Week Range:
$73.85
$74.18
52-Week Range:
$51.90
$84.39
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
73.91 | 16.45B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
534.28 | 187.89B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
178.71 | 51.42B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.89 | 36.71B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
246.88 | 36.82B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
282.07 | 20.04B | 2.96B | 487.70M | 344.00M | 6.6758 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-18-25 | Upgrade | Argus | Hold → Buy |
| Aug-06-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| May-27-25 | Reiterated | Needham | Hold |
| Mar-03-25 | Downgrade | Argus | Buy → Hold |
| Feb-06-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-03-25 | Downgrade | Needham | Buy → Hold |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
October M&A: Bristol Myers, Thermo Fisher, Hologic and Boston Scientific - The Business Journals
X-Ray System Markets Trends and Forecasts, 2020-2024 & - GlobeNewswire
Mammography Devices Market Trends and Forecasts Report 2025-2033, Profiles of Key PlayersHologic, Siemens Healthineers, GE Healthcare, Fujifilm, and Philips Healthcare - Yahoo! Finance Australia
How high can Hologic Inc. stock goPortfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com
How Hologic Inc. (HO1) stock reacts to weak economyWeekly Loss Report & Verified Momentum Watchlists - newser.com
U.S., Europe, and Asia Pacific Molecular Diagnostics Market - openPR.com
How Hologic Inc. (HO1) stock responds to bond marketBond Market & Risk Controlled Swing Trade Alerts - newser.com
Why retail investors pile into Hologic Inc. stockTrade Exit Summary & Expert Curated Trade Ideas - newser.com
Will Hologic Inc. stock attract ESG investorsJuly 2025 Highlights & Low Risk Entry Point Tips - newser.com
Hologic Inc. recovery potential after sell offEarnings Trend Report & Weekly High Return Forecasts - newser.com
Hologic Q4 2025 Earnings Preview - MSN
What margin trends mean for Hologic Inc. stockEarnings Growth Summary & Reliable Price Breakout Signals - newser.com
How Hologic Inc. stock benefits from tech adoptionOil Prices & Community Supported Trade Ideas - newser.com
Assessing Hologic’s Outlook After New Launches and an 8.3% Share Price Jump - Yahoo Finance
How to recover losses in Hologic Inc. stockRate Cut & Consistent Return Strategy Ideas - newser.com
Using Ichimoku Cloud for Hologic Inc. technicalsJuly 2025 Gainers & Community Supported Trade Ideas - newser.com
Statistical indicators supporting Hologic Inc.’s strengthJuly 2025 Outlook & Growth Oriented Trade Recommendations - newser.com
Hologic (HOLX) Reports Q3: Everything You Need To Know Ahead Of Earnings - TradingView
HOLOGIC Earnings Preview: Recent $HOLX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Hologic Q3’25 slides: modest growth continues amid mixed segment performance By Investing.com - Investing.com South Africa
Hologic Q3’25 slides: modest growth continues amid mixed segment performance - Investing.com
Earnings call transcript: Hologic’s Q3 2025 shows stable growth - Investing.com
Hologic Inc. stock momentum explainedRate Hike & Reliable Price Breakout Signals - newser.com
Should you hold or exit Hologic Inc. now2025 Stock Rankings & Safe Entry Trade Reports - newser.com
Real time breakdown of Hologic Inc. stock performanceOil Prices & Community Supported Trade Ideas - newser.com
Is Hologic Inc. (HO1) stock bottoming after sell offGap Up & Daily Profit Maximizing Trade Tips - newser.com
HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment? - TradingView
Gear Up for Hologic (HOLX) Q4 Earnings: Wall Street Estimates for Key Metrics - sharewise.com
Best data tools to analyze Hologic Inc. stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):